Wuxi Bio submitted its disclosure report on September 11, 2024, disclosing the changes in its issued shares and treasury shares. The report showed that based on the 2016 share plan, Wuxi Bio issued 10,000 ordinary shares on September 11, 2024, at a price of HKD 2.64 per share, bringing the total number of issued shares to 4,153,531,696 shares. In addition, the company conducted multiple share repurchases from June to September 2024, with a total repurchased quantity of 29,530,000 shares, at a repurchase price ranging from HKD 10.89 to HKD 11.13. All repurchased shares will be cancelled. Wuxi Bio confirmed that all share issuance and repurchase activities have been approved by the board of directors and complied with relevant listing rules and regulations. After the repurchase activities, Wuxi Bio will enter a one-month moratorium period until October 11, 2024.

Wuxi Bio submitted its disclosure report on September 11, 2024, disclosing the changes in its issued shares and treasury shares. The report showed that based on the 2016 share plan, Wuxi Bio issued 10,000 ordinary shares on September 11, 2024, at a price of HKD 2.64 per share, bringing the total number of issued shares to 4,153,531,696 shares. In addition, the company conducted multiple share repurchases from June to September 2024, with a total repurchased quantity of 29,530,000 shares, at a repurchase price ranging from HKD 10.89 to HKD 11.13. All repurchased shares will be cancelled. Wuxi Bio confirmed that all share issuance and repurchase activities have been approved by the board of directors and complied with relevant listing rules and regulations. After the repurchase activities, Wuxi Bio will enter a one-month moratorium period until October 11, 2024.